Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Ca2+
95%
Oxidative Phosphorylation (OXPHOS)
91%
IACS-010759
67%
RGS2
61%
Acute Myeloid Leukemia
45%
Hippocampal Neurons
45%
Cultured Hippocampal Neurons
40%
Voltage-dependent Activation
38%
Channel Complex
38%
Presynaptic Ca2+ Channels
38%
G Protein
36%
Advanced Solid Tumors
30%
Male Aggression
30%
Rhodopsin
30%
Phase I Trial
30%
Green Algae
30%
Neural Activity
30%
Network Activity
30%
Vertebrates
30%
Phosphogluconate Dehydrogenase
30%
Presynaptic Terminal
30%
Channelrhodopsin-2 (ChR2)
30%
Neurobehavioral Phenotype
30%
CAV2
30%
Apoptosis
30%
Tumor Regression
30%
Bispecific Antibody
30%
Pancreatic Cancer
30%
CDH3
30%
Capicua
30%
Ca2+ Channels
30%
Complex Causes
30%
Serotonergic System
30%
Functional Genomics
30%
Complex I Inhibitor
30%
Ataxin-1
30%
Targeting Mechanism
30%
Cancer Vulnerability
30%
Voltage Gating
30%
Derived Peptide
30%
G Protein Signaling
30%
Short-term Synaptic Plasticity
30%
K+ Channels
30%
Serotonergic Neurons
24%
Voltage-gated Ca2+ Channels
23%
Paired-pulse Facilitation
21%
Subcellular Structure
20%
Single-molecule Fluorescence Resonance Energy Transfer (smFRET)
17%
Amino Acids/peptides
17%
Antitumor Activity
16%
Biochemistry, Genetics and Molecular Biology
Electric Potential
61%
Oxidative Phosphorylation
61%
Programmed Cell Death
38%
Calcium Channel
30%
G Protein
30%
Functional Genomics
30%
Phosphogluconate Dehydrogenase
30%
Potassium Channel
30%
Synthetic Lethality
30%
Serotonergic
30%
Ataxin 1
30%
Drive
30%
RGS2
30%
Peptide
30%
Myeloid
22%
Antineoplastic Activity
20%
Cancer Cell
20%
Small Molecule
12%
Glycolysis
12%
Hyperactivity
12%
Genetics
10%
Caspase
10%
CRISPR/Cas9
10%
Deficiency
10%
Fluorescence Resonance Energy Transfer
9%
Amino Acid
9%
Aspartic Acid
7%
Electron Transport Chain
7%
Clinical Trial
7%
Nucleotide Metabolism
7%
Tumor Progression
7%
C-Fos
6%
Social Interaction
6%
Adrenergic Receptor
6%
Loss of Function Mutation
6%
Immediate Early Gene
6%
Gain of Function Mutation
6%
Mouse Mutant
6%
Maturation
6%
Transcriptional Repressor
6%
Intellectual Disability
6%
Oncogene C Fos
6%
Protein Subunit
5%
Carboxylation
5%
Homeostasis
5%
Glutamine
5%
Action Potential
5%
Nicotinamide Adenine Dinucleotide Phosphate
5%
Cell Membrane
5%
Transcription
5%
Neuroscience
Calcium Channel
100%
Behavior (Neuroscience)
42%
Synaptic Plasticity
38%
G Protein
36%
Potassium Channel
36%
Channelrhodopsin
30%
Rhodopsin
30%
Serotonergic
30%
Ataxin 1
30%
Regulator of G Protein Signalling
30%
Serotonergic System
30%
Peptide
30%
Neurotransmitter Release
20%
Receptor
15%
Synaptic Vesicle Release
15%
Hypothalamus
13%
Neuronal Excitability
12%
Synaptic Transmission
12%
Spinal Cord
12%
Action Potential
11%
Energy Transfer
9%
Amino Acid
9%
Presynaptic Terminal
7%
Synapse
7%
Ventromedial Nucleus
7%
Immediate Early Gene
7%
Adrenergic Receptor
7%
C-Fos
7%
Dorsal Raphe Nucleus
7%
Pertussis Toxin
6%
Chick
6%
Neurodegeneration
6%
Social Interaction
6%
Amygdala
6%
Learning Disability
6%
Attention Deficit Hyperactivity Disorder
6%
Hyperactivity
6%
Repressor
6%
Loss of Function Mutation
6%
Gain of Function Mutation
6%
Intellectual Disability
6%
Autism Spectrum Disorder
6%
Protein Subunit
5%
Cell Membrane
5%
